Use Able AI chat for product recommendations

Anti-Human BCMA/TNFRSF17 Rabbit Recombinant Antibody, PBS Only

BCMA/TNFRSF17 Uni-rAb® Recombinant Antibody for FC

Cat No. 98215-1-PBS
Clone No. 241731A11
Review Product
Download datasheet

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

FC

TNFRSF17, 241731A11, B-cell maturation protein, BCM, BCMA

Formulation:  PBS Only
PBS, Azide
PBS Only
Conjugate:  Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for BCMA/TNFRSF17 in ?

Product Information

98215-1-PBS targets BCMA/TNFRSF17 in FC applications and shows reactivity with human samples.

Tested Reactivity human
Host / Isotype Rabbit / IgG
Class Recombinant
Type Antibody
Immunogen

CatNo: Eg1812

Product name: Recombinant Human BCMA/TNFRSF17 protein (rFc Tag)

Source: mammalian cells-derived, pHZ-KIsec-C-rFc

Tag: C-rFc

Domain: 1-54 aa of BC058291

Sequence: MLQMAGQCSQNEYFDSLLHACIPCQLRCSSNTPPLTCQRYCNASVTNSVKGTNA

Predict reactive species
Full Name tumor necrosis factor receptor superfamily, member 17
Calculated Molecular Weight 184 aa, 20 kDa
GenBank Accession NumberBC058291
Gene Symbol TNFRSF17
Gene ID (NCBI) 608
RRIDAB_3745882
Conjugate Unconjugated
FormLiquid
Purification MethodProtein A purification
UNIPROT IDQ02223
Storage Buffer PBS only, pH 7.3.
Storage ConditionsStore at -80°C.

Background Information

BCMA (B cell maturation antigen), also known as TNFRSF17, is 20.2-kDa type III transmembrane glycoprotein and is a member of the TNF-receptor superfamily. This receptor is preferentially expressed in mature B lymphocytes and plasma cells, which may be important for B cell development and autoimmune response (PMID: 32943087; 9846698). BCMA has two agonist ligands: a proliferation-inducing ligand (APRIL) and BAFF. When BCMA binds to APRIL, it transmits signals of cell survival and proliferation (PMID: 27127303); when BCMA binds to BAFF, it mediates the activation of NF-kappaB and MAPK8/JNK (PMID: 36140254). It has been found that the overexpression and activation of BCMA are associated with multiple myeloma (MM) in preclinical models and humans, supporting its potential utility as a therapeutic target for MM (PMID: 32055000; 32943087).

Loading...
||
New chat

Able™

正在加载,请稍候...